Last reviewed · How we verify

NCT05567822: esmolol

The Impact of Esmolol Administration on Postoperative Recovery

Status unknown NA Last updated 27 October 2022
What this trial tests

NA trial testing Esmolol Hydrochloride in Pain, Acute in 70 participants. Status unknown.

Timeline
1 October 2022
Primary endpoint
1 October 2024
1 October 2024

Quick facts

Lead sponsorAretaieion University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment70
Start date1 October 2022
Primary completion1 October 2024
Estimated completion1 October 2024
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Aretaieion University Hospital

Who can join

Adults 18 to 75, any sex, with Pain, Acute or Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study will be to investigate the effect of a continuous infusion of low dose esmolol on intraoperative and postoperative opioid consumption, as well as on postoperative recovery and chronic pain

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Esmolol Hydrochloride

Trials testing the same drug.

Other recruiting trials for Pain, Acute

Currently open trials in the same condition.

Other Aretaieion University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05567822.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing